Cite
Wu AK, Damico NJ, Healy E, et al. Thyroid-optimized and thyroid-sparing radiotherapy in oral cavity and oropharyngeal carcinoma: A dosimetric study. Tech Innov Patient Support Radiat Oncol. 2021;20:28-34doi: 10.1016/j.tipsro.2021.10.003.
Wu, A. K., Damico, N. J., Healy, E., Kharouta, M. Z., Khandel, G., Deshane, A., Sipos, J., Eckstein, J., Zoller, W., Ewing, A., Ling, S., Wobb, J., Mitchell, D., Grecula, J., Jhawar, S., Miller, E., Gamez, M., Diavolitsis, V., Blakaj, D., & Bhatt, A. D. (2021). Thyroid-optimized and thyroid-sparing radiotherapy in oral cavity and oropharyngeal carcinoma: A dosimetric study. Technical innovations & patient support in radiation oncology, 2028-34. https://doi.org/10.1016/j.tipsro.2021.10.003
Wu, Anna K, et al. "Thyroid-optimized and thyroid-sparing radiotherapy in oral cavity and oropharyngeal carcinoma: A dosimetric study." Technical innovations & patient support in radiation oncology vol. 20 (2021): 28-34. doi: https://doi.org/10.1016/j.tipsro.2021.10.003
Wu AK, Damico NJ, Healy E, Kharouta MZ, Khandel G, Deshane A, Sipos J, Eckstein J, Zoller W, Ewing A, Ling S, Wobb J, Mitchell D, Grecula J, Jhawar S, Miller E, Gamez M, Diavolitsis V, Blakaj D, Bhatt AD. Thyroid-optimized and thyroid-sparing radiotherapy in oral cavity and oropharyngeal carcinoma: A dosimetric study. Tech Innov Patient Support Radiat Oncol. 2021 Nov 01;20:28-34. doi: 10.1016/j.tipsro.2021.10.003. eCollection 2021 Dec. PMID: 34765751; PMCID: PMC8571516.
Copy
Download .nbib